|Description||Bioresorbable Scaffold Technology Firm|
|Series A, 2/2012 |
North Bridge Venture Partners
|Partial Close, 4/2013 ||$18M|
|Debt, 10/2012 ||$5M|
480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery (SFA). Its lead product, SFA scaffold, is a proprietary scaffold and delivery system for use in treating peripheral arterial disease in the SFA. The company was founded in 2011 and is based in Watertown, Massachusetts.